Scientists Deploy MIBI Technology for Spatial Analysis of HIV Infection Model

Jun 15, 2021

New approach provides spatial multi-omic analysis of an HIV model

In a new preprint posted to bioRxiv, scientists at Stanford University, Oregon Health & Science University, and the Dana-Farber Cancer Institute report findings from the multi-omic analysis of an HIV model. The study was used to validate a new approach they call PANINI (short for protein and nucleic acid in situ imaging) that can be paired with multiplexed ion beam imaging (MIBI™) technology to study proteins and nucleic acids in the same tissue sample.

Eradication of HIV will require a deeper understanding of how the virus hunkers down in host cells, creating tissue reservoirs that are remarkably difficult for the body’s immune system to find and fight off. “To understand the mechanisms and pathology of HIV persistence it is necessary to visualize the tissue microenvironments where the virus resides,” writes Sizun Jiang, one of the lead authors on the manuscript. “However, technological barriers have limited our ability to phenotypically characterize and quantify the cellular components of viral tissue reservoirs.”

Jiang et al HIV infection model - MIBI image

Spatial biology platforms have empowered visualization of biomolecules, but what the scientists really wanted was a comprehensive view of proteins, DNA, and RNA at the same time — not just one type of analyte. Conventional ISH approaches typically require a processing step that is not ideal with simultaneous protein detection, so a new approach was needed.

PANINI-MIBI enables RNA, DNA, and protein imaging in FFPE tissue

The team turned to a new method that they named PANINI. Designed to be paired with a system like our MIBI technology, this approach carefully preserves both nucleic acids and proteins by circumventing protease digestion for a spatially resolved, multi-omic view of the tissue sample.

To demonstrate its utility, scientists used the PANINI-MIBI combination to analyze more than 30 parameters in FFPE samples and lymphoid tissues from rhesus macaques, studying both healthy animals and ones infected with simian immunodeficiency virus (SIV), a model for HIV. This allowed them “to characterize in unprecedented detail the viral reservoir and immune responses,” the team reports. “This enabled multiplexed dissection of cellular phenotypes, functional markers, viral DNA integration events, and viral RNA transcripts as resulting from viral infection.” They identified 11 types of cellular neighborhoods and found markers that could differentiate among healthy cells, cells with acute infection, and cells with chronic infection.

Jiang et al HIV infection model - cell types and cell neighborhoods
Jiang et al HIV infection model - cellular neighborhoods

Unlocking the mystery of cellular reservoirs in HIV

The researchers identified a number of traits that appear correlated with virus reservoirs. For instance, infected cells were more likely to be found in regions with dense B cell populations. They tend not to transcribe viral genes when they’re near the vascular system, but often produce transcripts when they’re near follicular dendritic cells. “Additional contributing features that distinguish between viral latency and transcription include the expression of CD56, and quantities of Tregs, neutrophils and CD8 T cells,” they add.

Jiang et al HIV infection model - single cell phenotype landscape
The authors suggest their approach could be useful for future studies of infectious disease, particularly with archival tissue specimens. The pairing of PANINI and MIBI technology, together with well-validated antibodies, “will be essential for advancing the mechanistic insights needed to better guide therapeutic intervention strategies,” they conclude. This technology was developed to be compatible with Formalin-Fixed Paraffin-Embedded (FFPE) tissues, the main mode of inactivation used for the study of highly pathogenic viruses such as SARS-CoV-2, Ebola and Marburg, thus opening up opportunities for future studies into high containment pathogens.

This study was lead by postdoctoral fellows Sizun Jiang, Ph.D (Stanford), Chan Chi Ngan (OHSU) and Xavier Rovira-Clave (Stanford), with senior authors Michael Angelo (Stanford), Jacob Estes (OHSU) and Garry Nolan (Stanford). The study was generously supported by various funding agencies, including the National Institutes of Health, the US Food and Drug Administration Medical Countermeasures Initiative and the Bill and Melinda Gates Foundation.

Contact Us

Let us know how we can help you.

    Immuno-oncology/CancerNeuroscienceInfectious DiseaseImmunologyStem CellOther


    Contact Us

    We are using cookies on our website

    Please confirm, if you accept our tracking cookies. You can also decline the tracking and continue to visit our website without any data sent to third-party services.